Browse Our Library of Libraries
Drug the Undruggable
We’re writing the future of biologics discovery with a best-in-class platform, our library of phage display libraries (known as the “Library of Libraries”), for hard-to-drug targets.
Downstream Liabilities Removed
Focused Sequence Space
Broad Array of Libraries
Expand Your Discovery Opportunities
Our pre-constructed, validated phage display libraries are built using our precision DNA writing technology, allowing us to remove motifs that can lead to downstream manufacturing liabilities and focus only on the applicable sequence space. Twist Biopharma has designed multiple general, naïve, and target-focused libraries with diversities ~1010, giving you a multifaceted approach to your next discovery project.
Antibody Discovery in As Little As a Few Months
Our collection of off-the-shelf libraries enable you to quickly identify high-quality leads against your target of interest using multiple strategies in only a few months. Select from libraries containing naïve human diversity, rationally designed with antibody structural considerations, or with diversity computationally tailored to high-value targets, including carbohydrates, hyperimmune, and structural motifs. They’re available in a variety of VHH, Fab, and scFv frameworks. These libraries can also be leveraged to develop monoclonal antibodies, multi-specifics, and chimeric antigen receptors (CARs) for CAR-T cell therapy.
Watch the Webinar
Developing Therapeutics Against Virtually Any Target with New Antibody Libraries
Poster
Product Sheet
Webinar
